Drug Post-Launch Activities

Drug Post Launch Activities

Post-launch activities for a new drug require companies to rigorously track, report, and evaluate worldwide adverse event information. Such drug post-launch activities are critically important to ensure current benefit/risk profiles and the dissemination of labeling that fully describes the safe use of a drug product. Continue reading

Drug Labeling

Drug Labeling

Our team of full time professional staff and expert consultants are well-versed in the nuances of professional and promotional labeling including website review.
Continue reading

Specialty Services

Imagine the value of continuous access to the specialty pharmaceutical consulting services and resources necessary to complete tasks that are out of the ordinary, unexpected, or for which you just don’t have time. Continue reading

Quality Assurance & Compliance

Quality Assurance & Compliance

For over 15 years, PDG has helped pharmaceutical firms achieve and maintain compliance with global Good Clinical Practice (GCP), Good Laboratory Practice (GLP), Good Manufacturing Practice (GMP) and pharmacovigilance (PV) standards.
Continue reading

Scientific and Technical Writing

PDG’s experienced technical writers include scientists and industry professionals who routinely draft and compile persuasive regulatory and scientific analyses. Our depth of experience in the preparation of such material positions us to address your communication needs in a variety of ways.

Continue reading

Supplier/Vendor Selection and Qualification

PDG Consulting – Supplier/Vendor Selection and Qualification

Years of service to the pharmaceutical industry, across a diverse range of drug development projects, has taught PDG that supplier/vendor selection, audit, qualification, contract negotiation, and oversight are critical to a successful drug development program.
Continue reading